BG102589A - 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists - Google Patents

3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists

Info

Publication number: BG102589A
Authority: BG; Bulgaria
Prior art keywords: antagonists; tachykin; azetidinylalkylpiperidines; pyrrolidines; compounds
Prior art date: 1996-01-05

Application number

BG102589A

Other languages

Bulgarian (bg)

English (en)

Inventor

Alexander MACKENZIE

Allan MARCHINGTON

Donald MIDDLETON

Sandra MEADOWS

Original Assignee

Pfizer Research And Development Company, N.V./S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-05

Filing date

1998-06-30

Publication date

1999-09-30

1998-06-30 Application filed by Pfizer Research And Development Company, N.V./S.A. filed Critical Pfizer Research And Development Company, N.V./S.A.

1999-09-30 Publication of BG102589A publication Critical patent/BG102589A/xx

Links

239000005557 antagonist Substances 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
102000003141 Tachykinin Human genes 0.000 abstract 1
108060008037 tachykinin Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyrane Compounds (AREA)
Pyrrole Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BG102589A 1996-01-05 1998-06-30 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists BG102589A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9600235.7A GB9600235D0 (en)	1996-01-05	1996-01-05	Therapeutic agents
PCT/EP1996/005613 WO1997025322A1 (en)	1996-01-05	1996-12-09	3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists

Publications (1)

Publication Number	Publication Date
BG102589A true BG102589A (en)	1999-09-30

Family

ID=10786682

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG102589A BG102589A (en)	1996-01-05	1998-06-30	3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists

Country Status (38)

Country	Link
US (1)	US6242438B1 (de)
EP (1)	EP0871623B1 (de)
JP (2)	JP3123611B2 (de)
KR (1)	KR100275402B1 (de)
AP (1)	AP709A (de)
AR (2)	AR005338A1 (de)
AT (1)	ATE232526T1 (de)
AU (1)	AU708282B2 (de)
BG (1)	BG102589A (de)
BR (1)	BR9612412A (de)
CA (1)	CA2237189C (de)
CO (1)	CO4750815A1 (de)
CZ (1)	CZ209398A3 (de)
DE (1)	DE69626220T2 (de)
DK (1)	DK0871623T3 (de)
DZ (1)	DZ2155A1 (de)
ES (1)	ES2190486T3 (de)
GB (1)	GB9600235D0 (de)
HR (1)	HRP970006A2 (de)
HU (1)	HUP9903590A3 (de)
IL (2)	IL124309A (de)
IS (1)	IS1876B (de)
MA (1)	MA26417A1 (de)
NO (1)	NO311838B1 (de)
NZ (1)	NZ324712A (de)
OA (1)	OA10863A (de)
PE (1)	PE29798A1 (de)
PL (1)	PL185723B1 (de)
RU (1)	RU2158264C2 (de)
SI (1)	SI0871623T1 (de)
SK (1)	SK89598A3 (de)
TN (1)	TNSN96174A1 (de)
TR (1)	TR199801268T2 (de)
TW (1)	TW472054B (de)
UY (1)	UY24429A1 (de)
WO (1)	WO1997025322A1 (de)
YU (1)	YU71496A (de)
ZA (1)	ZA9747B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9714129D0 (en) *	1997-07-04	1997-09-10	Pfizer Ltd	Azetidines
AU1089599A (en) *	1997-10-15	1999-05-03	Coelacanth Chemical Corporation	Synthesis of azetidine derivatives
ES2243012T3 (es) *	1997-12-04	2005-11-16	Sankyo Company Limited	Derivados heterociclicos aliciclicos acilados.
GB9821898D0 (en) *	1998-10-08	1998-12-02	Pfizer Ltd	Heterocycles
WO2001095904A1 (en) *	2000-06-12	2001-12-20	University Of Rochester	Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
US6642226B2 (en) *	2001-02-06	2003-11-04	Hoffman-La Roche Inc.	Substituted phenyl-piperidine methanone compounds
GB0130261D0 (en) *	2001-12-18	2002-02-06	Pfizer Ltd	Lactams as tachykinin antagonists
PL373410A1 (en) *	2002-02-01	2005-08-22	F.Hoffman-La Roche Ag	Substituted indoles as alpha-1 agonists
US7674783B2 (en) *	2002-11-22	2010-03-09	Dimera Inc.	Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
CA2509406C (en) *	2002-12-23	2012-07-03	Janssen Pharmaceutica N.V.	Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
TW200508221A (en)	2003-06-13	2005-03-01	Astrazeneca Ab	New azetidine compounds
EP1498123A1 (de) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Emulgierende Systeme enthaltend Azetidin Derivate
WO2006012226A2 (en)	2004-06-24	2006-02-02	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
US20060009491A1 (en) *	2004-06-24	2006-01-12	Incyte Corporation	Amido compounds and their use as pharmaceuticals
NZ556628A (en)	2005-03-08	2009-09-25	Janssen Pharmaceutica Nv	Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
AR057828A1 (es)	2005-09-29	2007-12-19	Astrazeneca Ab	Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
US8106208B2 (en)	2006-05-18	2012-01-31	Albireo Ab	Benzamide compounds that act as NK receptor antagonists
US8093268B2 (en)	2007-01-24	2012-01-10	Glaxo Group Limited	Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
RU2402546C2 (ru) *	2008-11-20	2010-10-27	Федеральное государственное учреждение "27 Научный центр Министерства Обороны Российской Федерации"	Способ получения метил 4-[(3,4-дихлорфенил)ацетил]-3-[(1-пирролидинил)метил]-1-пиперазинкарбоксилата
TW201026666A (en) *	2008-12-16	2010-07-16	Astrazeneca Ab	Quaternary piperidine derivatives and uses thereof
AU2010239188B2 (en) *	2009-04-22	2016-03-31	Janssen Pharmaceutica Nv	Azetidinyl diamides as monoacylglycerol lipase inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4226998A (en) *	1974-09-26	1980-10-07	Ciba-Geigy Corporation	1-Benzothiepin-4-carboxamides
GB1600880A (en) *	1978-05-23	1981-10-21	Lilly Industries Ltd	Pharmaceutical compositions comprising hydantoin derivatives
SU1032752A1 (ru) *	1981-08-14	1990-11-07	Институт биохимии АН ЛитССР	Калиева соль 4-(пиперидиназо)-N-ацетилбензолсульфамида, обладающа противовоспалительной активностью
SE8904298D0 (sv) *	1989-12-21	1989-12-21	Astra Ab	New compounds
IL99320A (en) *	1990-09-05	1995-07-31	Sanofi Sa	Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2676055B1 (fr)	1991-05-03	1993-09-03	Sanofi Elf	Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1994026735A1 (en) *	1993-05-06	1994-11-24	Merrell Dow Pharmaceuticals Inc.	Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
GB9315808D0 (en) *	1993-07-30	1993-09-15	Merck Sharp & Dohme	Therapeutic agents
JPH09507500A (ja) *	1994-01-13	1997-07-29	メルクシヤープエンドドームリミテツド	ｇｅｍ二置換アザシクロ系のタキキニン拮抗薬
FR2719311B1 (fr) *	1994-03-18	1998-06-26	Sanofi Sa	Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2717804B1 (fr)	1994-03-25	1996-06-21	Sanofi Sa	Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
TW432061B (en)	1994-08-09	2001-05-01	Pfizer Res & Dev	Lactams
WO1997022604A1 (en)	1995-12-20	1997-06-26	Hoechst Marion Roussel, Inc.	Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
GB9601202D0 (en) *	1996-01-22	1996-03-20	Pfizer Ltd	Piperidones
GB9812037D0 (en) *	1998-06-04	1998-07-29	Pfizer Ltd	Piperidones
GB9821898D0 (en) *	1998-10-08	1998-12-02	Pfizer Ltd	Heterocycles

1996
- 1996-01-05 GB GBGB9600235.7A patent/GB9600235D0/en active Pending
- 1996-12-06 TW TW085115107A patent/TW472054B/zh not_active IP Right Cessation
- 1996-12-09 DK DK96943119T patent/DK0871623T3/da active
- 1996-12-09 PL PL96327665A patent/PL185723B1/pl not_active IP Right Cessation
- 1996-12-09 RU RU98114667/04A patent/RU2158264C2/ru not_active IP Right Cessation
- 1996-12-09 DE DE69626220T patent/DE69626220T2/de not_active Expired - Fee Related
- 1996-12-09 ES ES96943119T patent/ES2190486T3/es not_active Expired - Lifetime
- 1996-12-09 SI SI9630590T patent/SI0871623T1/xx unknown
- 1996-12-09 CA CA002237189A patent/CA2237189C/en not_active Expired - Fee Related
- 1996-12-09 TR TR1998/01268T patent/TR199801268T2/xx unknown
- 1996-12-09 SK SK895-98A patent/SK89598A3/sk unknown
- 1996-12-09 IL IL12430996A patent/IL124309A/en not_active IP Right Cessation
- 1996-12-09 WO PCT/EP1996/005613 patent/WO1997025322A1/en not_active Ceased
- 1996-12-09 IL IL14532496A patent/IL145324A0/xx unknown
- 1996-12-09 HU HU9903590A patent/HUP9903590A3/hu unknown
- 1996-12-09 EP EP96943119A patent/EP0871623B1/de not_active Expired - Lifetime
- 1996-12-09 US US09/297,736 patent/US6242438B1/en not_active Expired - Fee Related
- 1996-12-09 KR KR1019980705159A patent/KR100275402B1/ko not_active Expired - Fee Related
- 1996-12-09 BR BR9612412A patent/BR9612412A/pt not_active Application Discontinuation
- 1996-12-09 JP JP09520769A patent/JP3123611B2/ja not_active Expired - Fee Related
- 1996-12-09 NZ NZ324712A patent/NZ324712A/xx unknown
- 1996-12-09 AT AT96943119T patent/ATE232526T1/de not_active IP Right Cessation
- 1996-12-09 CZ CZ982093A patent/CZ209398A3/cs unknown
- 1996-12-09 AU AU11950/97A patent/AU708282B2/en not_active Ceased
- 1996-12-19 AP APAP/P/1996/000901A patent/AP709A/en active
- 1996-12-27 PE PE1996000960A patent/PE29798A1/es not_active Application Discontinuation
- 1996-12-31 YU YU71496A patent/YU71496A/sr unknown
- 1996-12-31 DZ DZ960200A patent/DZ2155A1/fr active
- 1996-12-31 TN TNTNSN96174A patent/TNSN96174A1/fr unknown
- 1996-12-31 MA MA24446A patent/MA26417A1/fr unknown
1997
- 1997-01-02 AR ARP970100003A patent/AR005338A1/es unknown
- 1997-01-02 AR ARP970100004A patent/AR005339A1/es unknown
- 1997-01-03 ZA ZA9747A patent/ZA9747B/xx unknown
- 1997-01-03 UY UY24429A patent/UY24429A1/es not_active Application Discontinuation
- 1997-01-03 HR HR9600235.7A patent/HRP970006A2/xx not_active Application Discontinuation
- 1997-01-07 CO CO97000263A patent/CO4750815A1/es unknown
1998
- 1998-05-28 IS IS4760A patent/IS1876B/is unknown
- 1998-05-29 OA OA9800066A patent/OA10863A/en unknown
- 1998-06-09 NO NO19982651A patent/NO311838B1/no unknown
- 1998-06-30 BG BG102589A patent/BG102589A/xx unknown
2000
- 2000-05-10 JP JP2000136658A patent/JP3254205B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IS1876B (is)	2003-05-28
HUP9903590A3 (en)	2002-01-28
US6242438B1 (en)	2001-06-05
PL327665A1 (en)	1998-12-21
PE29798A1 (es)	1998-06-11
IL124309A0 (en)	1998-12-06
SK89598A3 (en)	2000-02-14
ATE232526T1 (de)	2003-02-15
ES2190486T3 (es)	2003-08-01
DK0871623T3 (da)	2003-03-31
DE69626220D1 (de)	2003-03-20
JP3123611B2 (ja)	2001-01-15
IS4760A (is)	1998-05-28
AP9600901A0 (en)	1997-01-31
EP0871623B1 (de)	2003-02-12
TR199801268T2 (xx)	1998-10-21
MA26417A1 (fr)	2004-12-20
CA2237189A1 (en)	1997-07-17
RU2158264C2 (ru)	2000-10-27
EP0871623A1 (de)	1998-10-21
ZA9747B (en)	1998-09-30
PL185723B1 (pl)	2003-07-31
KR19990077027A (ko)	1999-10-25
AU1195097A (en)	1997-08-01
AR005339A1 (es)	1999-04-28
CO4750815A1 (es)	1999-03-31
GB9600235D0 (en)	1996-03-06
NO982651L (no)	1998-06-09
HUP9903590A2 (hu)	2000-05-28
BR9612412A (pt)	1999-07-13
AR005338A1 (es)	1999-04-28
DZ2155A1 (fr)	2002-10-26
KR100275402B1 (ko)	2000-12-15
SI0871623T1 (en)	2003-08-31
HRP970006A2 (en)	1998-06-30
OA10863A (en)	2001-09-27
AU708282B2 (en)	1999-07-29
JPH11501667A (ja)	1999-02-09
YU71496A (en)	1999-11-22
CA2237189C (en)	2002-09-03
UY24429A1 (es)	2001-08-27
AP709A (en)	1998-12-22
NO982651D0 (no)	1998-06-09
DE69626220T2 (de)	2003-08-28
JP3254205B2 (ja)	2002-02-04
NO311838B1 (no)	2002-02-04
IL145324A0 (en)	2002-06-30
WO1997025322A1 (en)	1997-07-17
JP2000344741A (ja)	2000-12-12
NZ324712A (en)	1999-05-28
CZ209398A3 (cs)	1999-04-14
TW472054B (en)	2002-01-11
IL124309A (en)	2002-11-10
TNSN96174A1 (fr)	2005-03-15

Publication	Publication Date	Title
GR3030668T3 (en)	1999-10-29	Condensed indole derivatives as 5ht 4?-receptor antagonists.
EP0857718A4 (de)	1999-07-28	Endothelin-antagonisten
PL331900A1 (en)	1999-08-16	1,4-heterocyclic inhibitors of metaloprotease
PL331838A1 (en)	1999-08-02	1,3-diheterocyclic inhibitors of metaloproteases
AU2957997A (en)	1997-12-09	1,2,4-oxadiazoles as adhesion-receptor antagonists
MX9802383A (es)	1998-08-30	Derivados de pirimidina como antagonistas del receptor 5ht26.
GB9002504D0 (en)	1990-04-04	Novel cyclosporin galenic forms
BG103310A (en)	2000-05-31	Benzonaphthyridins as bronchial therapeutical means
CA2237189A1 (en)	1997-07-17	3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
ID16298A (id)	1997-09-18	Turunan-turunan 1,2,3,4-tetrahidronaftalena yang disubstitusi
HUP9904622A3 (en)	2001-07-30	1,4-di-sustituted piperidines as muscarinic antagonists
EP1017980A4 (de)	2002-09-18	Verfahren zur identifizierung pharmazeutisch aktiver verbindungen
PL330277A1 (en)	1999-05-10	Derivatives of 2,4-diaminopyrimidine
IL135648A0 (en)	2001-05-20	Novel 3, 6-hemiketals from the class of 9a-azalides
PL353875A1 (en)	2003-12-01	Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists
IL134572A0 (en)	2001-04-30	Substituted 1,2,3,4,5,6-hexahydro-2,6- methano-3-benzazocine-10-oles, methods for the production and use thereof as medicaments
BG103649A (en)	2000-06-30	Method for the preparation of eprosartan
IL128500A (en)	2003-06-24	SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BG103650A (en)	2000-06-30	Method for the preparation of eprosartan
MX9603199A (es)	1997-07-31	Antagonistas de receptores a endotelina.
GB9705861D0 (en)	1997-05-07	Trypthophan ureas as neurokinin antagonists
IL129858A0 (en)	2000-02-29	The use of polyether-polyurethane for safety clothing
HU9402436D0 (en)	1994-10-28	2,6-method-2h-quinolizin derivative as 5-ht3-receptor antagonist
PL328514A1 (en)	1999-02-01	1,4-dihydropyridine compounds as antagonists of bradykinin
ZA988397B (en)	1999-03-24	Process for the preparation of substituted 5,6-dihydro-2H-pyran-2-ones